medi-500
mAbexperimental
Clinical trial activity
0 trials · 0 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
0
Phase 3
0
Phase 4
0
Mechanism of action
- T-cell receptorANTAGONIST
T-cell receptor antagonist
Targets aß heterodimer of the T cell receptor, resulting in modulation of the receptor of the surface of the targeted T cells and apoptosis, not mitogenic and has a reduced capacity to stimulate the production of inflammatory cytokines.
Chemistry & pharmacology
- Chirality
- Single Stereoisomer
- Inorganic
- No
- Polymer
- No
- Multi-specific
- No
Oral
No
Parenteral
No
Topical
No
Sources
- ChEMBLCHEMBL2109592 ↗
Also known as
- alpha-beta t cell receptor antibody t10b9
- medi 500
- medi-500
- medi-500
- t10b9
- t10b9 alpha, beta t cell receptor antibody
- t10b9 antibody